Reduce falls with treadmill training
- Trial ID
- NCT07058285
- Official Title
- Steps Against the Burden of Parkinson's Disease
- Goal
- Reduce falls with treadmill training
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Kiel
- Study Type
- INTERVENTIONAL
- Enrollment
- 42 participants
- Conditions
- Parkinson Disease, Fall
- Interventions
- Speed-dependent treadmill training (SDTT), SDTT+ anteroposterior perturbations
Plain-Language Summary
The goal is to reduce falls and improve walking stability and adaptability in people with Parkinson's who have mild to moderate disease and noticeable gait problems. The approach uses speed-dependent treadmill training, where the belt speed responds to your stepping to build steadier, more adaptable gait, and some sessions add brief forward and backward perturbations to practice automatic recovery from trips and slips. This is a rehab therapy that complements medications rather than replacing them. The trial is seeking people diagnosed with Parkinson's by MDS criteria, Hoehn and Yahr stages I to III, with at least mild gait impairment on the MDS-UPDRS, who can give informed consent and walk at least one floor, and who do not have severe depression, major cognitive impairment, implanted deep brain stimulation, or other conditions that make unsupervised exercise unsafe.
Locations
- University of Kiel, Kiel, Germany
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Speed-dependent treadmill training (SDTT). The goal is to reduce falls and improve walking stability and adaptability in people with Parkinson's who have mild to moderate disease and noticeable gait problems. The approach uses speed-dependent treadmill training, where the belt speed responds to your stepping to build steadier, more adaptable gait, and some sessions add brief forward and backward perturbations to practice automatic recovery from trips and slips. This is a rehab therapy that complements medications rather than replacing them. The trial is seeking people diagnosed with Parkinson's by MDS criteria, Hoehn and Yahr stages I to III, with at least mild gait impairment on the MDS-UPDRS, who can give informed consent and walk at least one floor, and who do not have severe depression, major cognitive impairment, implanted deep brain stimulation, or other conditions that make unsupervised exercise unsafe.
- Who can participate?
- Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 8 months.